StonvexLoading…
StonvexStonvexStonvexCore line items from MPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $972.02M | $995.55M | $871.80M | $1.54B |
Operating Income | $-237.32M | $-2.36B | $-686.77M | $959.72M |
Net Income | $-277.05M | $-2.41B | $-556.48M | $902.60M |
EPS (Diluted) | $-0.46 | $-4.02 | $-0.93 | $1.50 |
Total Assets | $15.00B | $14.29B | $18.30B | $19.66B |
Total Liabilities | $10.39B | $9.46B | $10.67B | $11.06B |
Cash & Equivalents | $540.86M | $332.33M | $250.02M | $235.67M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 597.01M | 600.40M | 598.99M | 597.48M |